Scoggin Management’s Allergan plc AGN Stock Holding History

Scoggin Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-48,000	Closed	-$11.1M	–	62
2016 Q3	$11.1M	Buy	48,000 +1,000	+2%	+$244K	1.9%	17
2016 Q2	$10.9M	Buy	+47,000	New	+$10.8M	1.22%	18

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Scoggin Management's AGN Position: Q1 2017 in Review

Scoggin Management sold out of Allergan plc (AGN) in Q1 2017, closing a stake of 24,000 shares — an estimated $5.04M sold.

Scoggin Management first reported a position in AGN in Q2 2013 and held it in 12 quarters. The position peaked at $40.2M in Q4 2015. 1,104 funds tracked by Wall St. Rank hold AGN as of Q1 2017.

Scoggin Management reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
Scoggin Management sold 24,000 Allergan plc shares in Q1 2017, an estimated $5.04M.
Scoggin Management first reported a position in Allergan plc in Q2 2013 and held it in 12 quarters.
Scoggin Management's Allergan plc position peaked at $40.2M in Q4 2015.
1,104 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Scoggin Management's 13F filing for Q1 2017, filed 12 May 2017.